Endogenous nociceptin (orphanin FQ) suppresses basal hedonic state and acute reward responses to methamphetamine and ethanol, but facilitates chronic responses

Neuropsychopharmacology

Volumn 33, Issue 4, 2008, Pages 877-891

  Sakoori, Kazuto ^a   Murphy, Niall P ^a  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

Addiction; Ethanol; Methamphetamine; Opioid; Reward

Indexed keywords

ALCOHOL; KAPPA OPIATE RECEPTOR AGONIST; LITHIUM CHLORIDE; METHAMPHETAMINE; NALOXONE; NOCICEPTIN; NOCICEPTIN RECEPTOR ANTAGONIST; OPIATE ANTAGONIST; UFP 01; UNCLASSIFIED DRUG;

ADDICTION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONDITIONING; CONTROLLED STUDY; FEMALE; LEARNING; LOCOMOTION; MALE; MOUSE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; REWARD; WILD TYPE;

ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CENTRAL NERVOUS SYSTEM STIMULANTS; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ETHANOL; MALE; METHAMPHETAMINE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OPIOID PEPTIDES; RECEPTORS, OPIOID; REWARD; TIME FACTORS;

EID: 39149096584     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301459     Document Type: Article

References (81)

1. Achat-Mendes C, Ali SF, Itzhak Y (2005). Differential effects of amphetamines-induced neurotoxicity on appetitive and aversive Pavlovian conditioning in mice. Neuropsychopharmacology 30: 1128-1137.
2. Bardo MT (1998). Neuropharmacological mechanisms of drug reward: beyond dopamine in the nucleus accumbens. Crit Rev Neurobiol 12: 37-67.
3. Bardo MT, Bevins RA (2000). Conditioned place preference: what does it add to our preclinical understanding of drug reward? Psychopharmacology (Berl) 153: 31-43.
4. Berrendero F, Kieffer BL, Maldonado R (2002). Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in mu-opioid receptor knock-out mice. J Neurosci 22: 10935-10940.
5. Bjijou Y, De Deurwaerdere P, Spampinato U, Stinus L, Cador M (2002). D-amphetamine-induced behavioral sensitization: effect of lesioning dopaminergic terminals in the medial prefrontal cortex, the amygdala and the entorhinal cortex. Neuroscience 109: 499-516.
6. Blakley GG, Pohorecky LA, Benjamin D (2004). Behavioral and endocrine changes following antisense oligonucleotide-induced reduction in the rat NOP receptor. Psychopharmacology (Berl) 171: 421-428.
7. Bouwknecht JA, Hijzen TH, van der Gugten J, Maes RA, Hen R, Olivier B (2000). Ethanol intake is not elevated in male 5-HT(1B) receptor knockout mice. Eur J Pharmacol 403: 95-98.
8. Brown JM, Gouty S, Iyer V, Rosenberger J, Cox BM (2006). Differential protection against MPTP or methamphetamine toxicity in dopamine neurons by deletion of ppN/OFQ expression. J Neurochem 98: 495-505.
9. Buzas B, Symes AJ, Cox BM (1999). Regulation of nociceptin/orphanin FQ gene expression by neuropoietic cytokines and neurotrophic factors in neurons and astrocytes. J Neurochem 72: 1882-1889.
10. Chu CP, Kunitake T, Kato K, Watanabe S, Qiu DL, Tanoue A et al (2004). The alpha 1D-adrenergic receptor modulates cardiovascular and drinking responses to central salt loading in mice. Neurosci Lett 356: 33-36.
11. Chung S, Pohl S, Zeng J, Civelli O, Reinscheid RK (2006). Endogenous orphanin FQ/nociceptin is involved in the development of morphine tolerance. J Pharmacol Exp Ther 318: 262-267.
12. Ciccocioppo R, Angeletti S, Sanna PP, Weiss F, Massi M (2000). Effect of nociceptin/orphanin FQ on the rewarding properties of morphine. Eur J Pharmacol 404: 153-159.
13. Ciccocioppo R, Economidou D, Fedeli A, Angeletti S, Weiss F, Heilig M et al (2004a). Attenuation of ethanol self-administration and of conditioned reinstatement of alcohol-seeking behaviour by the antiopioid peptide nociceptin/orphanin FQ in alcohol-preferring rats. Psychopharmacology (Berl) 172: 170-178.
14. Ciccocioppo R, Economidou D, Fedeli A, Heilig M, Massi M (2004b). Inhibition of ethanol drinking by buprenorphine: evidence for the involvement of the nociceptin/orphanin fq receptor system. 2004 Abstract Viewer/Itinerary Planner. Society for Neuroscience: Washington, DC, 2004. Online. Program No. 691.10.
15. Ciccocioppo R, Economidou D, Fedeli A, Massi M (2003). The nociceptin/orphanin FQ/NOP receptor system as a target for treatment of alcohol abuse: a review of recent work in alcohol-preferring rats. Physiol Behav 79: 121-128.
16. Ciccocioppo R, Economidou D, Rimondini R, Sommer W, Massi M, Heilig M (2006). Buprenorphine reduces alcohol drinking through activation of the nociceptin/orphanin FQ-NOP receptor system. Biol Psychiatry 6: 4-12.
17. Ciccocioppo R, Panocka I, Polidori C, Regoli D, Massi M (1999). Effect of nociceptin on alcohol intake in alcohol-preferring rats. Psychopharmacology (Berl) 141: 220-224.
18. Ciccocioppo R, Polidori C, Antonelli L, Salvadori S, Guerrini R, Massi M (2002). Pharmacological characterization of the nociceptin receptor which mediates reduction of alcohol drinking in rats. Peptides 23: 117-125.
19. Cifani C, Guerrini R, Massi M, Polidori C (2006). Chronic intracerebroventricular infusion of nociceptin/orphanin FQ increases food and ethanol intake in alcohol-preferring rats. Peptides 27: 2803-2810.
20. Contarino A, Picetti R, Matthes HW, Koob GF, Kieffer BL, Gold LH (2002). Lack of reward and locomotor stimulation induced by heroin in mu-opioid receptor-deficient mice. Eur J Pharmacol 446: 103-109.
21. Davidson D, Palfai T, Bird C, Swift R (1999). Effects of naltrexone on alcohol self-administration in heavy drinkers. Alcohol Clin Exp Res 23: 195-203.
22. Di Giannuario A, Pieretti S, Catalani A, Loizzo A (1999). Orphanin FQ reduces morphine-induced dopamine release in the nucleus accumbens: a microdialysis study in rats. Neurosci Lett 272: 183-186.
23. Economidou D, Fedeli A, Fardon RM, Weiss F, Massi M, Ciccocioppo R (2006). Effect of novel nociceptin/orphanin FQNOP receptor ligands on ethanol drinking in alcohol-preferring msP rats. Peptides 27: 3299-3306.
24. Fahlke C, Hansen S, Engel JA, Hard E (1994). Effects of ventral striatal 6-OHDA lesions or amphetamine sensitization on ethanol consumption in the rat. Pharmacol Biochem Behav 47: 345-349.
25. Florin S, Suaudeau C, Meunier JC, Costentin J (1996). Nociceptin stimulates locomotion and exploratory behaviour in mice. Eur J Pharmacol 317: 9-13.
26. Gavioli EC, Marzola G, Guerrini R, Bertorelli R, Zucchini S, De Lima TC et al (2003). Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test. Eur J Neurosci 17: 1987-1990.
27. Gehrke BJ, Harrod SB, Cass WA, Bardo MT (2003). The effect of neurotoxic doses of methamphetamine on methamphetamine-conditioned place preference in rats. Psychopharmacology (Berl) 166: 249-257.
28. Hall FS, Goeb M, Li XF, Sora I, Uhl GR (2004). mu-Opioid receptor knockout mice display reduced cocaine conditioned place preference but enhanced sensitization of cocaine-induced locomotion. Brain Res Mol Brain Res 121: 123-130.
29. Hall FS, Sora I, Uhl GR (2001). Ethanol consumption and reward are decreased in mu-opiate receptor knockout mice. Psychopharmacology (Berl) 154: 43-49.
30. Hungund BL, Szakall I, Adam A, Basavarajappa BS, Vadasz C (2003). Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol-induced dopamine release in the nucleus accumbens. J Neurochem 84: 698-704.
31. Itzhak Y, Martin JL, Ali SF (2002). Methamphetamine-induced dopaminergic neurotoxicity in mice: long-lasting sensitization to the locomotor stimulation and desensitization to the rewarding effects of methamphetamine. Prog Neuropsychopharmacol Biol Psychiatry 26: 1177-1183.
32. Kadota T, Kadota K (2004). Neurotoxic morphological changes induced in the medial prefrontal cortex of rats behaviorally sensitized to methamphetamine. Arch Histol Cytol 67: 241-251.
33. Kapusta DR (2000). Neurohumoral effects of orphanin FQ/ nociceptin: relevance to cardiovascular and renal function. Peptides 21: 1081-1099.
34. Kieffer BL, Gaveriaux-Ruff C (2002). Exploring the opioid system by gene knockout. Prog Neurobiol 66: 285-306.
35. Koizumi M, Midorikawa N, Takeshima H, Murphy NP (2004a). Exogenous, but not endogenous nociceptin modulates mesolimbic dopamine release in mice. J Neurochem 89: 257-263.
36. Koizumi M, Sakoori K, Midorikawa N, Murphy NP (2004b). The NOP (ORL1) receptor antagonist Compound B stimulates mesolimbic dopamine release and is rewarding in mice by a non-NOP-receptor-mediated mechanism. Br J Pharmacol 143: 53-62.
37. Koster A, Montkowski A, Schulz S, Stube EM, Knaudt K, Jenck F et al (1999). Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice. Proc Natl Acad Sci USA 96: 10444-10449.
38. Kotlinska J, Rafalski P, Biala G, Dylag T, Rolka K, Silberring J (2003). Nociceptin inhibits acquisition of amphetamine-induced place preference and sensitization to stereotypy in rats. Eur J Pharmacol 474: 233-239.
39. Kovacs KM, Szakall I, O'Brien D, Wang R, Vinod KY, Saito M et al (2005). Decreased oral self-administration of alcohol in kappa-opioid receptor knock-out mice. Alcohol Clin Exp Res 29: 730-738.
40. Kuzmin A, Sandin J, Terenius L, Ogren SO (2003). Acquisition, expression, and reinstatement of ethanol-induced conditioned place preference in mice: effects of opioid receptor-like 1 receptor agonists and naloxone. J Pharmacol Exp Ther 304: 310-318.
41. Kuzmin A, Sandin J, Terenius L, Ogren SO (2004). Evidence in locomotion test for the functional heterogeneity of ORL-1 receptors. Br J Pharmacol 141: 132-140.
42. Lett BT (1989). Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine. Psychopharmacology (Berl) 98: 357-362.
43. Li Y, Acerbo MJ, Robinson TE (2004). The induction of behavioural sensitization is associated with cocaine-induced structural plasticity in the core (but not shell) of the nucleus accumbens. Eur J Neurosci 20: 1647-1654.
44. Li Y, Kolb B, Robinson TE (2003). The location of persistent amphetamine-induced changes in the density of dendritic spines on medium spiny neurons in the nucleus accumbens and caudate-putamen. Neuropsychopharmacology 28: 1082-1085.
45. Longoni R, Cadoni C, Mulas A, Di Chiara G, Spina L (1998). Dopamine-dependent behavioural stimulation by non-peptide delta opioids BW373U86 and SNC 80: 2. Place-preference and brain microdialysis studies in rats. Behav Pharmacol 9: 9-14.
46. Lutfy K, Do T, Maidment NT (2001). Orphanin FQ/nociceptin attenuates motor stimulation and changes in nucleus accumbens extracellular dopamine induced by cocaine in rats. Psychopharmacology (Berl) 154: 1-7.
47. Lutfy K, Khaliq I, Carroll FI, Maidment NT (2002). Orphanin FQ/nociceptin blocks cocaine-induced behavioral sensitization in rats. Psychopharmacology (Berl) 164: 168-176.
48. Mamiya T, Noda Y, Nishi M, Takeshima H, Nabeshima T (1998). Enhancement of spatial attention in nociceptin/orphanin FQ receptor-knockout mice. Brain Res 783: 236-240.
49. Marti M, Mela F, Fantin M, Zucchini S, Brown JM, Witta J et al (2005). Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease. J Neurosci 25: 9591-9601.
50. Melis M, Spiga S, Diana M (2005). The dopamine hypothesis of drug addiction: hypodopaminergic state. Int Rev Neurobiol 63: 101-154.
51. Mitchell JM, Liang MT, Fields HL (2005). A single injection of the kappa opioid antagonist norbinaltorphimine increases ethanol consumption in rats. Psychopharmacology (Berl) 182: 384-392.
52. Murphy NP (2004). Nociceptin/orphanin FQ, hedonic state and the response to abused drugs. Nihon Shinkei Seishin Yakurigaku Zasshi 24: 295-298.
53. Murphy NP, Lam HA, Chen Z, Pintar JE, Maidment NT (2002). Heroin-induced locomotion and mesolimbic dopamine release is unchanged in mice lacking the ORL.1 receptor gene. Brain Res 953: 276-280.
54. Murphy NP, Lee Y, Maidment NT (1999). Orphanin FQ/nociceptin blocks acquisition of morphine place preference. Brain Res 832: 168-170.
55. Narayanan S, Lutfy K, Maidment N (2002). Sensitization to cocaine after a single intra-cerebral injection of orphanin FQ/nociceptin. Behav Brain Res 131: 97-103.
56. Narayanan S, Maidment NT (1999). Orphanin FQ and behavioral sensitization to cocaine. Pharmacol Biochem Behav 63: 271-277.
57. Nishi M, Houtani T, Noda Y, Mamiya T, Sato K, Doi T et al (1997). Unrestrained nociceptive response and disregulation of hearing ability in mice lacking the nociceptin/orphaninFQ receptor. EMBO J 16: 1858-1864.
58. Okabe C, Takeshima H, Murphy NP (2005). Methamphetamine sensitization in nociceptin receptor knockout mice: locomotor and c-fos expression. Eur J Pharmacol 507: 57-67.
59. Orsini C, Buchini F, Piazza PV, Puglisi-Allegra S, Cabib S (2004). Susceptibility to amphetamine-induced place preference is predicted by locomotor response to novelty and amphetamine in the mouse. Psychopharmacology (Berl) 172: 264-270.
60. Pan ZZ (1998). mu-Opposing actions of the kappa-opioid receptor. Trends Pharmacol Sci 19: 94-98.
61. Pierce RC, Bari AA (2001). The role of neurotrophic factors in psychostimulant-induced behavioral and neuronal plasticity. Rev Neurosci 12: 95-110.
62. Quarfordt SD, Kalmus GW, Myers RD (1991). Ethanol drinking following 6-OHDA lesions of nucleus accumbens and tuberculum olfactorium of the rat. Alcohol 8: 211-217.
63. Reinscheid RK (2006). The orphanin FQ/nociceptin receptor as a novel drug target in psychiatric disorders. CNS Neurol Disord Drug Targets 5: 219-224.
64. Ring RH, Alder J, Fennell M, Kouranova E, Black IB, Thakker-Varia S (2006). Transcriptional profiling of brain-derived-neurotrophic factor-induced neuronal plasticity: a novel role for nociceptin in hippocampal neurite outgrowth. J Neurobiol 66: 361-377.
65. Roberts AJ, Gold LH, Polis I, McDonald JS, Filliol D, Kieffer BL et al (2001). Increased ethanol self-administration in delta-opioid receptor knockout mice. Alcohol Clin Exp Res 25: 1249-1256.
66. Robinson TE, Berridge KC (2001). Incentive-sensitization and addiction. Addiction 96: 103-114.
67. Saito Y, Maruyama K, Saido TC, Kawashima S (1997). Overexpression of a neuropeptide nociceptin/orphanin FQ precursor gene, N23K/N27K, induces neurite outgrowth in mouse NS20Y cells. J Neurosci Res 48: 397-406.
68. Sakoori K, Murphy NP (2004). Central administration of nociceptin/orphanin FQ blocks the acquisition of conditioned place preference to morphine and cocaine, but not conditioned place aversion to naloxone in mice. Psychopharmacology (Berl) 172: 129-136.
69. Sakoori K, Murphy NP (2005). Maintenance of conditioned place preferences and aversion in C57BL6 mice: effects of repeated and drug state testing. Behav Brain Res 160: 34-43.
70. Sellings LH, Clarke PB (2006). 6-Hydroxydopamine lesions of nucleus accumbens core abolish amphetamine-induced conditioned activity. Synapse 59: 374-377.
71. Shimohira I, Tokuyama S, Himeno A, Niwa M, Ueda H (1997). Characterization of nociceptin-stimulated in situ [35S]GTPgammaS binding in comparison with opioid agonist-stimulated ones in brain regions of the mice. Neurosci Lett 237: 113-116.
72. Shippenberg TS, Heidbreder C (1995a). Sensitization to the conditioned rewarding effects of cocaine: pharmacological and temporal characteristics. J Pharmacol Exp Ther 273: 808-815.
73. Shippenberg TS, Heidbreder C (1995b). The delta-opioid receptor antagonist naltrindole prevents sensitization to the conditioned rewarding effects of cocaine. Eur J Pharmacol 280: 55-61.
74. Shoblock JR, Wichmann J, Maidment NT (2005). The effect of a systemically active ORL-1 agonist, Ro 64-6198, on the acquisition, expression, extinction, and reinstatement of morphine conditioned place preference. Neuropharmacology 49: 439-446.
75. Sim LJ, Childers SR (1997). Anatomical distribution of mu, delta, and kappa opioid- and nociceptin/orphanin FQ-stimulated [35S]guanylyl-5′-O- (gamma-thio)-triphosphate binding in guinea pig brain. J Comp Neurol 386: 562-572.
76. Taverna FA, Georgiou J, McDonald RJ, Hong NS, Kraev A, Salter MW et al (2005). Defective place cell activity in nociceptin receptor knockout mice with elevated NMDA receptor-dependent long-term potentiation. J Physiol 565: 579-591.
77. Thiele TE, Naveilhan P, Ernfors P (2004). Assessment of ethanol consumption and water drinking by NPY Y(2) receptor knockout mice. Peptides 25: 975-983.
78. Ueda H, Inoue M, Takeshima H, Iwasawa Y (2000). Enhanced spinal nociceptin receptor expression develops morphine tolerance and dependence. J Neurosci 20: 7640-7647.
79. Zaratin PF, Petrone G, Sbacchi M, Garnier M, Fossati C, Petrillo P et al (2004). Modification of nociception and morphine tolerance by the selective opiate receptor-like orphan receptor antagonist (-)-cis-1-methyl-7- [[4-(2,6-dichlorophenyl)piperidin-1-yl]-methyl]-6,7,8,9-tetrahydro-5H- benzocyclohepten-5-ol (SB-612111). J Pharmacol Exp Ther 308: 454-461.
80. Zavala AR, Weber SM, Rice HJ, Alleweireldt AT, Neisewander JL (2003). Role of the prelimbic subregion of the medial prefrontal cortex in acquisition, extinction, and reinstatement of cocaineconditioned place preference. Brain Res 990: 157-164.
81. Zhao RJ, Woo RS, Jeong MS, Shin BS, Kim DG, Kim KW (2003). Orphanin FQ/nociceptin blocks methamphetamine place preference in rats. Neuroreport 14: 2383-2385.